Actavis Group Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS GROUP, and what generic and branded alternatives to ACTAVIS GROUP drugs are available?
ACTAVIS GROUP has one approved drug.
Drugs and US Patents for Actavis Group
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Group | HALOPERIDOL | haloperidol | TABLET;ORAL | 200854-006 | Jul 1, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Group | HALOPERIDOL | haloperidol | TABLET;ORAL | 200854-002 | Jul 1, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Group | HALOPERIDOL | haloperidol | TABLET;ORAL | 200854-003 | Jul 1, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.